AEG: Analysis & Opinions

  1. Goldman Sachs Gets Into The Loan Business

    April 12, 2013
    Goldman Sachs’ decides to list a piece of Liberty Harbor Capital subsidiary as a BDC.
  2. US Nod for ISIS/Sanofi's Kynamro - Analyst Blog

    January 30, 2013
    The US Food and Drug Administration (FDA) recently approved Kynamro (mipomersen sodium) injection developed by ...
  3. Aegon Fortifies Romanian Operations - Analyst Blog

    January 30, 2013
    Aegon N.V. (AEG) will acquire the Romanian life insurance and pension facility of Eureko, a fully owned subsidiary ...
  4. Aegerion Prices Stock Offering - Analyst Blog

    January 14, 2013
    Aegerion Pharmaceuticals, Inc. (AEGR) recently provided more details on its public offering. The offering is ...
  5. Aegerion to Raise Funds - Analyst Blog

    January 11, 2013
    Aegerion Pharmaceuticals, Inc. (AEGR) recently announced its intention to raise funds through the issuance of its ...
  6. Aegerion Upbeat About 2013 - Analyst Blog

    January 08, 2013
    Aegerion Pharmaceuticals Inc. (AEGR) recently announced its 2013 guidance as the company prepares for the launch of ...
  7. Hartford Slips to Underperform - Analyst Blog

    December 31, 2012
    We have downgraded our recommendation on Hartford Financial Services Group Inc. (HIG) to 'Underperform' from ...
  8. Watson Pharmaceuticals, Inc and Other Big Movers In ...

    December 31, 2012
    Currently, the Nasdaq has climbed 0.6%, the S&P 500 has risen 0.2% and the Dow has been relatively flat. The ...
  9. Aegon partners with Banco Santander - Analyst Blog

    December 27, 2012
    Recently Aegon N.V. (AEG) announced a strategic alliance with Spain's largest financial group Banco Santander, for a ...
  10. FDA Approves Aegerion's Juxtapid - Analyst Blog

    December 26, 2012
    The US Food and Drug Administration (FDA) recently approved Aegerion Pharmaceuticals' (AEGR) Juxtapid (lomitapide) ...
  11. Amazon.com Among the Nasdaq's Biggest Movers on December ...

    December 26, 2012
    The market is down this morning. The Nasdaq is trading down 1.1%; the S&P 500 is down 0.6%; and the Dow has slipped ...
  12. Intuitive Surgical Among Healthcare's Biggest Movers on ...

    December 26, 2012
    The market is having a bad day so far: the Nasdaq has declined 1.1%; the S&P 500 is trading down 0.6%; and the Dow ...
  13. Panera and Other Big Movers on the Nasdaq on December ...

    December 21, 2012
    The market is down this morning. The Nasdaq has decreased 2%; the S&P 500 has slipped 1.9%; and the Dow is down ...
  14. Healthcare Stocks, Including Thermo Fisher, Making Big ...

    December 21, 2012
    On a bad day for the market, the Nasdaq has slipped 2%, the S&P 500 is trading down 1.9% and the Dow is down 1.4%. ...
  15. Healthcare Stocks, Including Regeneron Pharmaceuticals, ...

    December 19, 2012
    So far today, the Nasdaq is up 0.1%, the S&P 500 has slipped 0.1% and the Dow has remained steady. The healthcare ...
  16. CHMP Negative on Isis' Kynamro - Analyst Blog

    December 17, 2012
    The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently did not ...
  17. DaVita and Other Healthcare Stocks Making Big Moves on ...

    December 14, 2012
    It's been a bad day for the market after the morning's trading. The Nasdaq is trading down 0.8%; the S&P 500 has ...
  18. Eli Lilly and Other Healthcare Stocks Making Big Moves ...

    December 12, 2012
    The Nasdaq remains relatively unchanged, the S&P 500 has moved up 0.2% and the Dow is up 0.2% after the morning's ...
  19. Aegon to Acquire Ukrainian Company - Analyst Blog

    December 10, 2012
    Last week, AEGON N.V. (AEG) announced an agreement to acquire a 100% stake in Fidem Life from Horizon Capital - a ...
  20. FDA Panel Backs Isis' Kynamro - Analyst Blog

    October 22, 2012
    The US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee recently voted in ...
Marketplace
Trading Center